Compare Bundamedik Tbk (BMHS) vs Kian Santang Muliatama Tbk. (RGAS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bundamedik Tbk vs Kian Santang Muliatama Tbk. — how do they compare? Bundamedik Tbk trades at Rp189 (market cap 1.62T, 222.6K 24h volume), while Kian Santang Muliatama Tbk. trades at Rp189 (market cap 277.25B, 7.9M 24h volume). The key difference: Bundamedik Tbk is far larger — about 5.8× Kian Santang Muliatama Tbk.'s market cap, and Kian Santang Muliatama Tbk. is more actively traded (7.9M versus 222.6K). Which is the better fit depends on your goals.
| BMHS | RGAS | |
|---|---|---|
Market Cap | 1.62T | 277.25B |
Volume | 222.6K | 7.9M |
Lot | 2.23K | 79K |
Turnover | 42.02M | 1.5B |
Average Price | 188.79 | 189.43 |
Value | 42.02M | 1.5B |
Indicative Equilibrium Price | 189 | 189 |
Indicative Equilibrium Volume | 100 | 13.98K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Bundamedik Tbk
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →About Kian Santang Muliatama Tbk.
PT Kian Santang Muliatama Tbk (the Entity) was established based on the Notarial Deed of Artisa Khamelia Ramadiyanti, S.H., M.Kn., No. 634, dated November 28, 2018. The Entity started its commercial operations on 2019. The controlling party for the Company is Edy Nurhamid Amin.
Read more on RGAS →
